Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer

SIMPLE SUMMARY: Breast cancer-related deaths are mainly due to the spread of cancer cells to distant organs (a process termed metastasis). CD82, also known as KAI1, is an established metastasis suppressor that has been documented to be lowly expressed in metastatic breast cancer. Hence, CD82 could p...

Descripción completa

Detalles Bibliográficos
Autores principales: Viera, Maximillian, Yip, George Wai Cheong, Shen, Han-Ming, Baeg, Gyeong Hun, Bay, Boon Huat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431267/
https://www.ncbi.nlm.nih.gov/pubmed/34503296
http://dx.doi.org/10.3390/cancers13174486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431267/
https://www.ncbi.nlm.nih.gov/pubmed/34503296
http://dx.doi.org/10.3390/cancers13174486

Ejemplares similares